Skip to main content
SpringerLink
Log in

Handbook of Incretin-based Therapies in Type 2 Diabetes

  • Book
  • © 2016

Overview

Editors:
  1. Stephen Gough

    1. Oxford Ctre for Diabe, Endocrngy & Metab, Oxford University, Oxford, United Kingdom

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • A concise overview of ground breaking novel incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors

  • Ideal for busy clinicians who encounter patients with type 2 diabetes on a daily basis and are interested in a clinically-applicable introduction to incretin-based therapies

  • Includes the most up-to-date clinical guidelines, recent clinical trials and expert discussions of established and emerging therapies for patients with type 2 diabetes

  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (6 chapters)

  1. Front Matter

    Pages I-IX
    Download chapter PDF

  2. Introduction and disease overview

    • Sunder Mudaliar, Robert R. Henry
    Pages 1-9

  3. Incretin hormones as a target for therapy

    • Jens Juul Holst
    Pages 11-30

  4. Glucagon-like peptide-1 receptor agonists

    • Baptist Gallwitz
    Pages 31-43

  5. Dipeptidyl peptidase-4 inhibitors

    • Carolyn F Deacon
    Pages 45-60

  6. Guidelines and recommendations for use

    • Archana Dhere, Stephen C. L. Gough
    Pages 61-75

  7. Future and emerging therapies

    • Eduard Montanya
    Pages 77-92
Back to top

Keywords

About this book

This concise handbook provides an overview of incretin-based therapies and guidance for incorporating them into the treatment of type 2 diabetes. Chapters include landmark clinical trials and international treatment guidelines in order to update readers with all major advances in the field. An ideal resource for medical professionals that treat patients with type 2 diabetes in hospital and clinical settings.

Reviews

                                                                                                                                                                                                                                                                                                                                                                    

Editors and Affiliations

  • Oxford Ctre for Diabe, Endocrngy & Metab, Oxford University, Oxford, United Kingdom

    Stephen Gough

About the editor

Stephen Gough is Professor of Diabetes at the University of Oxford and Consultant Physician at the Oxford University Hospitals NHS Trust. Professor Gough graduated in medicine from Leeds University Medical School, where he was later awarded a higher degree Doctorate in Medicine, which focused on cardiac dysfunction and abnormalities in coagulation and fibrinolysis present at the time of diagnosis of type 2 diabetes. He is currently based at the Oxford Centre for Diabetes, Endocrinology and Metabolism, where he is a practicing clinician in diabetes. His research interests and ongoing research studies include translational aspects of diabetes, with a focus on the physiology of islet cell and whole organ pancreas transplantation, incretin biology, and incretin therapies in diabetes. Professor Gough has previously had a strong interest in the genetic susceptibility to autoimmunity and this work has been extended into his work on pancreas transplantation. He has published his research extensively in peer-reviewed journals and has contributed to many national and international conferences and books on diabetes. In recent years, Professor Gough has helped develop translation research in diabetes in Oxford through a number of local and national initiatives, including the Oxford Biomedical Research Centre, and he is Clinical Lead in Diabetes for the Oxford Academic Health Science Network and the Oxford Local Clinical Research Network.

Addendum

Since editing this book, Professor Gough has taken up the position of Senior Principal Clinical Scientist with Novo Nordisk. He continues as Visiting Professor of Diabetes at the University of Oxford and Honorary Consultant with the Oxford University Hospitals NHS Trust.                                                                                                                                                                                                 

Bibliographic Information

  • Book Title: Handbook of Incretin-based Therapies in Type 2 Diabetes

  • Editors: Stephen Gough

  • DOI: https://doi.org/10.1007/978-3-319-08982-9

  • Publisher: Adis Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2016

  • Softcover ISBN: 978-3-319-08981-2Published: 17 June 2016

  • eBook ISBN: 978-3-319-08982-9Published: 07 June 2016

  • Edition Number: 1

  • Number of Pages: IX, 92

  • Number of Illustrations: 4 b/w illustrations, 16 illustrations in colour

  • Topics: Diabetes

Publish with us

Policies and ethics

Back to top

Search

Navigation